Viveon Health Acquisition... (VHAQ)
AMEX: VHAQ
· Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Jan 30, 2025, 9:00 PM
Viveon Health Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 367.57K | 570.64K | 741.37K | 756.39K | 1.71M | 1.5M | 1.33M | 1.05M | n/a | n/a | n/a |
Gross Profit | -367.57K | -570.64K | -741.37K | -756.39K | -1.71M | -1.5M | -1.33M | -1.05M | n/a | n/a | n/a |
Operating Income | -314.29K | -1.25M | -1.89M | -2.37M | -5M | -4.74M | -6.2M | -5.46M | -3.14M | -2.46M | -361.82K |
Interest Income | 415.87K | 646.5K | 712.19K | 725.12K | 314.39K | 88.91K | 28.31K | 20.48K | 15.34K | 10.19K | 5.09K |
Pretax Income | 3.17M | 787.61K | 1.26M | -425.48K | -5.29M | -1.73M | -2.62M | 2.49M | 4.32M | 3.15M | 3.56M |
Net Income | 3.21M | 825.8K | 1.3M | -486.79K | -5.29M | -1.73M | -2.62M | 2.49M | 4.32M | 3.15M | 3.56M |
Selling & General & Admin | -211.89K | 491.94K | 928.05K | 1.37M | 2.98M | 3.07M | 3.28M | 2.86M | 1.76M | 970.02K | 321.9K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 231.75K | 467.69K | 670.93K | 1M | 2.02M | 1.78M | 1.58M | 1.25M | -26.03K | -26.03K | -26.03K |
Operating Expenses | 434.25K | 1.37M | 2.01M | 2.79M | 5M | 4.85M | 4.86M | 4.11M | 1.73M | 943.99K | 295.87K |
Interest Expense | 2.55M | 3.29M | 3.55M | 3.65M | 1.1M | 359.29K | 99.54K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 702.92K | 1.64M | 2.28M | 2.79M | 5M | 4.85M | 6.08M | 5.33M | 2.95M | 2.16M | 295.87K |
Income Tax Expense | -38.19K | -38.19K | -38.19K | 61.31K | n/a | -110.07K | 1.34M | 1.36M | 1.36M | 1.47M | 13.89K |
Shares Outstanding (Basic) | 5.87M | 5.87M | 5.87M | 12.22M | 9.06M | 9.06M | 21.97M | 25.16M | 24.15M | 24.15M | 24.15M |
Shares Outstanding (Diluted) | 5.87M | 5.87M | 5.87M | 12.22M | 9.06M | 9.06M | 21.97M | 25.16M | 24.15M | 24.15M | 24.15M |
EPS (Basic) | 0.47 | 0.21 | 0.26 | 0.15 | -0.37 | -0.06 | -0.19 | 0.03 | 0.12 | 0.07 | 0.15 |
EPS (Diluted) | 0.47 | 0.21 | 0.26 | 0.15 | -0.36 | -0.05 | -0.18 | 0.04 | 0.12 | 0.07 | 0.15 |
EBITDA | 4.96M | 3.52M | 4.25M | 3.42M | -4.48M | -1.75M | -4.35M | 976.82K | 3.3M | 2.01M | 3.88M |
EBIT | 5.56M | 3.91M | 4.64M | 3.22M | -4.68M | -1.75M | -4.35M | 641.5K | 2.96M | 1.68M | 3.54M |
Depreciation & Amortization | 82.5K | 323.92K | 201.84K | 201.84K | 201.84K | n/a | n/a | 335.32K | 335.53K | 336K | 336K |